Bailard, Inc. Vanda Pharmaceuticals Inc. Transaction History
Bailard, Inc.
- $3.8 Billion
- Q1 2025
A detailed history of Bailard, Inc. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Bailard, Inc. holds 22,469 shares of VNDA stock, worth $97,066. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,469Holding current value
$97,066% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VNDA
# of Institutions
158Shares Held
44.7MCall Options Held
64.8KPut Options Held
562K-
Black Rock Inc. New York, NY8.14MShares$35.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.57MShares$15.4 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.5MShares$15.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$11 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.2 Million0.7% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $244M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...